UTRS News and Press, Minerva Surgical Inc. From 01/11/22

SANTA CLARA, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a medical device company that has established a broad product line of commercially available, minimally invasive medical devices that address the most common cause...

SANTA CLARA, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the 40 th Annual J.P. Morgan Healthcare Conferen...

Minerva Surgical (NASDAQ:UTRS) reports financial results for Q3 ended September 30, 2021. Shares surged 10.3% after-hours after the company's top-line exceeded analyst expectations. Q3 revenues reached $12.5M, ahead of analysts' forecast of $12.15M. The increase in revenue was prima...

Minerva Surgical (NASDAQ:UTRS): Q3 GAAP EPS of -$1.15 misses by $0.72. Revenue of $12.51M (+1.9% Y/Y) beats by $0.36M. Stock up 10% AH. Press Release For further details see: Minerva Surgical EPS misses by $0.72, beats on revenue

SANTA CLARA, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a medical device company that develops therapeutic devices that treat abnormal uterine bleeding in a minimally invasive manner, today reported financial results fo...

Minerva Surgical (UTRS -15.6%), which manufactures devices for uterine healthcare, reached a 52-week low earlier today of $6.13 Minerva just had its IPO last month, which was priced at $12 per share. Seeking Alpha contributor The Value Investor says he has "concerns about the competitiveness"...

SANTA CLARA, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will participate in the 33 rd Annual Piper Sandler Virtual Healt...

SANTA CLARA, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a women's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announces today the launch of a new consumer education experience for women: www.aubandme.com . The company...

Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports and conference presentatio...

Minerva Surgical aims to transform uterine healthcare with its minimally invasive procedures. I like the potential of the business, and despite the current growth, I wonder if the competitive strength of the solutions is strong enough. Given these dynamics, and despite modest sale...